Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.6610-6611
Main Authors: Diaz Duque, Adolfo Enrique, Karnad, Anand, Butler, Matthew James, Bowhay-Carnes, Elizabeth, Michalek, Joel E, Huelgas, Gabriela, Aguiar, Ricardo
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-167001